Figures & data
Table 1 Demographic and Preoperative Ocular Characteristics
Figure 1 Mean IOP through 24 months postoperative, all eyes (n=340).
![Figure 1 Mean IOP through 24 months postoperative, all eyes (n=340).](/cms/asset/87a4f8ca-318d-479a-9a0f-abd80920f949/doph_a_12176933_f0001_c.jpg)
Figure 2 Proportional analysis of IOP at 24 months vs preoperative, all eyes (n=340).
![Figure 2 Proportional analysis of IOP at 24 months vs preoperative, all eyes (n=340).](/cms/asset/21ecd41f-226e-4335-bbe2-f614e69ed22f/doph_a_12176933_f0002_c.jpg)
Figure 3 Mean number of medications through 24 months postoperative, all eyes (n=340).
![Figure 3 Mean number of medications through 24 months postoperative, all eyes (n=340).](/cms/asset/858bdd36-603b-4db3-a118-114114cbe2b1/doph_a_12176933_f0003_c.jpg)
Figure 4 Proportional analysis of medications at 24 months vs preoperative, all eyes (n=340).
![Figure 4 Proportional analysis of medications at 24 months vs preoperative, all eyes (n=340).](/cms/asset/9d60f199-983c-4955-9f71-278f0498ccff/doph_a_12176933_f0004_c.jpg)
Figure 5 IOP reduction by glaucoma subtype (p<0.01 for all).
![Figure 5 IOP reduction by glaucoma subtype (p<0.01 for all).](/cms/asset/f24d0f78-e39c-44e7-9efd-eab62a140986/doph_a_12176933_f0005_c.jpg)
Figure 6 Medication reduction by glaucoma subtype (p<0.001 for all).
![Figure 6 Medication reduction by glaucoma subtype (p<0.001 for all).](/cms/asset/2892e323-24be-42b1-8407-534c0e396250/doph_a_12176933_f0006_c.jpg)
Table 2 Preoperative and Month 24 CDR, VF MD, and CDVA Consistent Sets of Eyes with Data at Both Time Points